Cargando…

Patient advocacy organizations’ information for patients on pre-approval access to investigational treatments

OBJECTIVE: To evaluate the availability of information regarding patient access to investigational treatments through clinical trials and non-trial pre-approval access pathways from a sample of patient advocacy organization (PAO) websites in the United States. RESULTS: We systematically analyzed the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Folkers, Kelly McBride, Leone, Sarah, Caplan, Arthur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819417/ https://www.ncbi.nlm.nih.gov/pubmed/31661023 http://dx.doi.org/10.1186/s13104-019-4745-7

Ejemplares similares

Where Can Patients Obtain Information on the Preapproval Access Pathway to Investigational Treatment in Japan? A Survey of Patient Advocacy Organizations’ Websites
por: Nakada, Haruka, et al.
Publicado: (2019)

Characterizing expanded access and compassionate use programs for experimental drugs
por: Miller, Jennifer E., et al.
Publicado: (2017)

The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti‐integrin therapies
por: Dotan, Iris, et al.
Publicado: (2019)

A Patient‐Centric Model for Discontinuation of a Single‐Sourced Approved Drug
por: Caplan, Arthur, et al.
Publicado: (2019)

A Model of Advocacy to Inform Action
por: Earnest, Mark, et al.
Publicado: (2022)

Effect of COVID-19 on patient access to health services for noncommunicable diseases in Latin America: a perspective from patient advocacy organizations
por: Kruse, Meredith H., et al.
Publicado: (2022)

Prevention literacy: community-based advocacy for access and ownership of the HIV prevention toolkit
por: Parker, Richard G, et al.
Publicado: (2016)

A99 PHARMACEUTICAL INDUSTRY FUNDING TO GASTROINTESTINAL PATIENT ADVOCACY ORGANIZATIONS
por: Verma, Y, et al.
Publicado: (2022)

Patient advocacy: barriers and facilitators
por: Negarandeh, Reza, et al.
Publicado: (2006)

Patient advocacy and DSM-5
por: Stein, Dan J, et al.
Publicado: (2013)

Advocacy for patients with headache disorders
por: Gouider, Riadh, et al.
Publicado: (2023)

Disease advocacy organizations catalyze translational research
por: Terry, Sharon F.
Publicado: (2013)

What makes a compliant Phase III and pre-launch patient advocacy strategy?
por: Hicks, Nick, et al.
Publicado: (2016)

Research priorities to support evidence-informed policies and advocacy for access to safe abortion care in sub-Saharan Africa
por: Ajayi, Anthony Idowu, et al.
Publicado: (2021)

Collective forward-looking responsibility of patient advocacy organizations: conceptual and ethical analysis
por: Müller, Regina, et al.
Publicado: (2021)

‘Advocacy groups are the connectors’: Experiences and contributions of rare disease patient organization leaders in advanced neurotherapeutics
por: Nguyen, Christina Q., et al.
Publicado: (2022)

Alternative Action Organizations: Social Solidarity or Political Advocacy?
por: Giugni, Marco, et al.
Publicado: (2018)

Policy Advocacy and Nursing Organizations: A Scoping Review
por: Chiu, Patrick, et al.
Publicado: (2021)

Patient Advocacy in Research: Merely an Afterthought?
por: Mayer, Musa
Publicado: (2012)

Patient‐led research and Advocacy Efforts
por: Tsimicalis, Argerie, et al.
Publicado: (2022)

Patient Advocacy in Vascularized Composite Allotransplantation
por: Benedict, James
Publicado: (2022)

Patient advocacy: an antidote to loneliness and more
por: Walker, Sophia
Publicado: (2022)

Addressing a Crisis in Abortion Access: A Case Study in Advocacy
por: Lynch, Beatrice, et al.
Publicado: (2022)

The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network
por: Merkel, Peter A., et al.
Publicado: (2016)

Going “social” to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access
por: Mackey, Tim K., et al.
Publicado: (2016)

SIDECACHE: Information access, management and dissemination framework for web services
por: Doderer, Mark S, et al.
Publicado: (2011)

Challenges and opportunities for improving access to approved neonatal drugs and devices
por: Lewis, Tamorah, et al.
Publicado: (2022)

SAT374 Indirect and Intangible Burden of PCOS: A Patient Advocacy Organization Study
por: Thai, Linda, et al.
Publicado: (2023)

A Human Rights Approach to Emergency Response? The Advocacy of Canada's Human Rights Commissions during the COVID-19 Crisis
por: De Silva, Nicole
Publicado: (2020)

Access to Abortion After Dobbs v. Jackson Women’s Health Organization: Advocacy and a Call to Action for the Profession of Psychiatry
por: Coverdale, John, et al.
Publicado: (2022)

(R)evolution: toward a new paradigm of policy and patient advocacy for expanded access to experimental treatments
por: Hogan, Melissa
Publicado: (2016)

AIDS advocacy and intellectual property regulation in Brazil: information and influence
por: da Fonseca, Elize Massard, et al.
Publicado: (2014)

Accessing targeted therapies for cancer: self and collective advocacy alongside and beyond mainstream cancer charities
por: Kerr, Anne, et al.
Publicado: (2021)

Advocacy in neurology
por: Pauranik, Apoorva
Publicado: (2008)

Advocacy for Alzheimer’s
por: Isaac, Aimee
Publicado: (2021)

Advocacy Workshop
Publicado: (2008)

Headache advocacy
por: Grisold, Wolfgang, et al.
Publicado: (2023)

PATIENT ADVOCACY-01 WHY IS NEURO- ONCOLOGY MISSING FROM CIVIL SOCIETY CANCER ADVOCACY AGENDA?
por: Makumi, David, et al.
Publicado: (2023)

The African cancer advocacy consortium: shaping the path for advocacy in Africa
por: Odedina, Folakemi T, et al.
Publicado: (2013)

Advocacy, education, and the role of not-for-profit organizations in Lewy body dementias
por: Taylor, Angela, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1ul2dhg6ea5s82t47sasehushe